Fineos' (ASX:FCL) shares were up nearly 1% after the company said Monday that it entered a strategic partnership with Opifiny, a cloud-based platform that digitizes and streamlines medical information collection for underwriting, disability, and absence management.
Under the collaboration, medical information collected through Opifiny will flow directly into Fineos claims and absence processes.
Financial terms were not disclosed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.